Centauri's AlphamerTM Platform highlighted at 4th Annual Advances in Immuno-Oncology Congress
22 mai 2019 02h00 HE
|
Centauri Therapeutics Limited
Centauri's AlphamerTM Platform highlighted at 4th Annual Advances in Immuno-Oncology Congress UK, 22 May 2019: Centauri Therapeutics (“Centauri”), an immunotherapy...
Centauri Therapeutics to present at 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
10 avr. 2019 02h00 HE
|
Centauri Therapeutics Limited
Centauri Therapeutics to present at 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) UK, 10 April 2019: Centauri Therapeutics (“Centauri”), an immunotherapy...